- Generic name
- Eltrombopag
- Strength
- 25 mg
- Dosage form
- Tablet
- Manufactured by
- Renata PLC.
R-Pag 25 Tablet
About R-Pag 25 Tablet
R-Pag 25 25 mg is a tablet product of Renata PLC. that contains Eltrombopag. For the treatment of patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy.
There are 7 brands of Eltrombopag listed in Bangladesh.
What is R-Pag 25 Tablet?
R-Pag 25 comes as a tablet with 25 mg of Eltrombopag, from Renata PLC. For the treatment of patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy. For the treatment of thrombocytopenia in patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy. The doctor decides the dose and course.
Uses of R-Pag 25
For the treatment of patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy. For the treatment of thrombocytopenia in patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy. Ask your doctor whether it is right for your condition.
How to use R-Pag 25
Swallow the tablet with water. R-Pag 25 is taken by mouth. Take R-Pag 25 25 mg tablet by mouth as directed by your doctor. Complete the course exactly as prescribed. Do not change the dose or stop early without asking your doctor.
Side effects of R-Pag 25
He following clinically significant adverse reactions associated with Eltrombopag are described in other sections. Tell your doctor if any side effect bothers you or does not go away. Contact your doctor if you notice anything unusual after taking it.
Safety and precautions
The estimated background risk of major birth defects and miscarriage for the indicated population is unknown. Eltrombopag may increase the risk of severe and potentially life-threatening hepatotoxicity. Tell your doctor about all the other medicines you take.
Frequently asked questions
What is R-Pag 25 used for?
For the treatment of patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy. For the treatment of thrombocytopenia in patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy.
How should I take R-Pag 25?
Swallow the tablet with water. R-Pag 25 is taken by mouth.
What are the side effects of R-Pag 25?
He following clinically significant adverse reactions associated with Eltrombopag are described in other sections. Tell your doctor if any side effect bothers you or does not go away.
Can I use R-Pag 25 in pregnancy or while breastfeeding?
The estimated background risk of major birth defects and miscarriage for the indicated population is unknown. Eltrombopag may increase the risk of severe and potentially life-threatening hepatotoxicity.
Alternative brands of Eltrombopag
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.